A Trial to Evaluate the Impact of C21 on the Exposure of 4 Substrates in Healthy Volunteers
Clinical trial NCT05830799 · COMPLETED
Trial details
- NCT number
- NCT05830799
- Sponsor
- Vicore Pharma AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-29
- Primary completion
- 2023-05-11
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.